236 related articles for article (PubMed ID: 30338367)
1. Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.
Rani L; Gogia A; Singh V; Kumar L; Sharma A; Kaur G; Gupta R
Ann Hematol; 2019 Feb; 98(2):437-443. PubMed ID: 30338367
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients].
Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923
[No Abstract] [Full Text] [Related]
3. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
4. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
[TBL] [Abstract][Full Text] [Related]
5. The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.
Muñoz-Novas C; Poza-Santaella M; González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Infante MS; Heras C; Foncillas MÁ; Marín K; Hernández-Rivas JM; Hernández JÁ
Biomed Res Int; 2018; 2018():9506979. PubMed ID: 29736400
[TBL] [Abstract][Full Text] [Related]
6. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
7. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
8. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).
Jaramillo S; Agathangelidis A; Schneider C; Bahlo J; Robrecht S; Tausch E; Bloehdorn J; Hoechstetter M; Fischer K; Eichhorst B; Goede V; Hallek M; Döhner H; Rosenquist R; Ghia P; Stamatopoulos K; Stilgenbauer S
Haematologica; 2020 Nov; 105(11):2598-2607. PubMed ID: 33131249
[TBL] [Abstract][Full Text] [Related]
10. Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.
Molica S; Giannarelli D; Mirabelli R; Levato L; Russo A; Linardi M; Gentile M; Morabito F
Eur J Haematol; 2016 Jan; 96(1):72-7. PubMed ID: 25819739
[TBL] [Abstract][Full Text] [Related]
11. Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Hoechstetter MA; Busch R; Eichhorst B; Bühler A; Winkler D; Bahlo J; Robrecht S; Eckart MJ; Vehling-Kaiser U; Jacobs G; Jäger U; Hurtz HJ; Hopfinger G; Hartmann F; Fuss H; Abenhardt W; Blau I; Freier W; Müller L; Goebeler M; Wendtner C; Fischer K; Herling CD; Starck M; Bentz M; Emmerich B; Döhner H; Stilgenbauer S; Hallek M
Leukemia; 2020 Apr; 34(4):1038-1051. PubMed ID: 32042081
[TBL] [Abstract][Full Text] [Related]
12. Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
González-Gascón-Y-Marín I; Muñoz-Novas C; Figueroa I; Hernández-Sánchez M; Rodríguez-Vicente AE; Quijada-Álamo M; Pérez-Carretero C; Moreno C; Collado R; Espinet B; Puiggros A; Heras NL; Bosch F; Hernández JÁ;
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):548-555.e4. PubMed ID: 32389671
[TBL] [Abstract][Full Text] [Related]
13. The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.
Brieghel C; da Cunha-Bang C; Yde CW; Schmidt AY; Kinalis S; Nadeu F; Andersen MA; Jacobsen LO; Andersen MK; Pedersen LB; Delgado J; Baumann T; Mattsson M; Mansouri L; Rosenquist R; Campo E; Nielsen FC; Niemann CU
Clin Cancer Res; 2020 Mar; 26(6):1507-1515. PubMed ID: 31919133
[TBL] [Abstract][Full Text] [Related]
14. Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia.
Gao R; Chen RZ; Xia Y; Liang JH; Wang L; Zhu HY; Zhu Wu J; Fan L; Li JY; Yang T; Xu W
Int J Cancer; 2018 Aug; 143(3):466-477. PubMed ID: 29457831
[TBL] [Abstract][Full Text] [Related]
15. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
[TBL] [Abstract][Full Text] [Related]
16. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL
Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367
[TBL] [Abstract][Full Text] [Related]
17. The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysis.
Molica S; Giannarelli D; Gentile M; Cutrona G; Di Renzo N; Di Raimondo F; Neri A; Federico M; Ferrarini M; Morabito F
Leuk Res; 2013 Aug; 37(8):943-7. PubMed ID: 23499499
[TBL] [Abstract][Full Text] [Related]
18. The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity.
Davis Z; Forconi F; Parker A; Gardiner A; Thomas P; Catovsky D; Rose-Zerilli M; Strefford JC; Oscier D
Br J Haematol; 2016 Apr; 173(1):127-36. PubMed ID: 26846718
[TBL] [Abstract][Full Text] [Related]
19. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.
Van Dyke DL; Werner L; Rassenti LZ; Neuberg D; Ghia E; Heerema NA; Dal Cin P; Dell Aquila M; Sreekantaiah C; Greaves AW; Kipps TJ; Kay NE
Br J Haematol; 2016 Apr; 173(1):105-13. PubMed ID: 26848054
[TBL] [Abstract][Full Text] [Related]
20. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
